Andrew Cittadine - 01 Jun 2021 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Operating Officer
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-Fact
Issuer symbol
MNPR
Transactions as of
01 Jun 2021
Transactions value $
$0
Form type
4
Filing time
02 Jun 2021, 16:11:49 UTC
Next filing
02 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +70K $0.00 70K 01 Jun 2021 Common Stock 70K $5.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 6/48ths on November 30, 2021 and 1/48th monthly on the last day of each month thereafter.